DOCT — Beyond Medical Technologies Balance Sheet
0.000.00%
Last trade - 00:00- CA$19.17m
- CA$18.98m
- 14
- 18
- 72
- 26
Annual balance sheet for Beyond Medical Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.624 | 1.43 | 0.537 | 0.064 | 0.013 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.097 | 0.028 | 0.006 | 0.003 | 0.001 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.19 | 1.81 | 0.579 | 0.096 | 0.014 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.612 | 0.114 | 0 | — | — |
| Other Long Term Assets | |||||
| Total Assets | 1.84 | 1.95 | 0.608 | 0.096 | 0.014 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.274 | 0.413 | 0.347 | 0.43 | 0.634 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.362 | 0.413 | 0.347 | 0.43 | 0.634 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 1.48 | 1.54 | 0.261 | -0.335 | -0.621 |
| Total Liabilities & Shareholders' Equity | 1.84 | 1.95 | 0.608 | 0.096 | 0.014 |
| Total Common Shares Outstanding |